DEINOVE signe une licence d'évaluation et de développement technologique avec DSM DEINOVE signe une licence d'évaluation et de développement technologique avec DSM DEINOVE (Euronext Growth Paris : ALDEI), société de biotechnologie française pionnière dans l’exploration et...

DEINOVE signs an Evaluation and Technology Development License with DSM DEINOVE signs an Evaluation and Technology Development License with DSM DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that pioneers the application of biodiversity from the...

2020 Half-year results: Stronger financial position and research programs moving forward despite the international context 2020 Half-year results: Stronger financial position and research programs moving forward despite the international context Clinical program for the antibiotic candidate DNV3837 continues, with the...

Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Company's strategy for innovation and partnerships Alexis RIDEAU has recognized experience in the development, negotiation and implementation of strategic partnerships in the life sciences field, particularly in microbiology applied to health and...